Role of gut microbiota in type 2 diabetes pathophysiology

被引:913
|
作者
Gurung, Manoj [1 ]
Li, Zhipeng [1 ]
You, Hannah [1 ]
Rodrigues, Richard [2 ]
Jump, Donald B. [3 ]
Morgun, Andrey [2 ]
Shulzhenko, Natalia [1 ]
机构
[1] Oregon State Univ, Coll Vet Med, 700 SW 30th St, Corvallis, OR 97331 USA
[2] Oregon State Univ, Coll Pharm, 160 SW 26th St, Corvallis, OR 97331 USA
[3] Oregon State Univ, Coll Publ Hlth, 160 SW 26th St, Corvallis, OR 97331 USA
来源
EBIOMEDICINE | 2020年 / 51卷
关键词
Type; 2; diabetes; Microbiota; 16S rRNA; Metagenomics; Insulin resistance; HIGH-FAT DIET; LACTOBACILLUS-CASEI CCFM419; INSULIN-RESISTANCE; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOTA; BARIATRIC SURGERY; METABOLIC PROFILES; GLUCOSE-TOLERANCE; OXIDATIVE STRESS; GLYCEMIC CONTROL;
D O I
10.1016/j.ebiom.2019.11.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A substantial body of literature has provided evidence for the role of gut microbiota in metabolic diseases including type 2 diabetes. However, reports vary regarding the association of particular taxonomic groups with disease. In this systematic review, we focused on the potential role of different bacterial taxa affecting diabetes. We have summarized evidence from 42 human studies reporting microbial associations with disease, and have identified supporting preclinical studies or clinical trials using treatments with probiotics. Among the commonly reported findings, the genera of Bifidobacterium, Bacteroides, Faecalibacterium, Akkermansia and Roseburia were negatively associated with T2D, while the genera of Ruminococcus, Fusobacterium, and Blautia were positively associated with T2D. We also discussed potential molecular mechanisms of microbiota effects in the onset and progression of T2D. (C) 2019 The Authors. Published by Elsevier B.V.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Pathophysiology of Type 1 Diabetes and Gut Microbiota Role
    Del Chierico, Federica
    Rapini, Novella
    Deodati, Annalisa
    Matteoli, Maria Cristina
    Cianfarani, Stefano
    Putignani, Lorenza
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [2] The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
    Baars, Daniel P.
    Fondevila, Marcos F.
    Meijnikman, Abraham S.
    Nieuwdorp, Max
    [J]. CELL HOST & MICROBE, 2024, 32 (08) : 1280 - 1300
  • [3] Role of Gut Microbiota in Pathogenesis and Treatment of Type 2 Diabetes
    Duggal, Navneet
    Kapoor, Sumir
    [J]. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2021, 5 (02): : 103 - 110
  • [4] Role of the gut microbiota in type 2 diabetes and related diseases
    Yang, Ge
    Wei, Jinlong
    Liu, Pinyi
    Zhang, Qihe
    Tian, Yuan
    Hou, Guowen
    Meng, Lingbin
    Xin, Ying
    Jiang, Xin
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 117
  • [5] Metagenomic Insights on the Role of Gut Microbiota in Type-2 Diabetes
    Lobiuc, Andrei
    Pavel, Ionut
    Toderean, Roxana
    Avatamanitei, Sebastian
    Covasa, Mihai
    [J]. 2019 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB), 2019,
  • [6] Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbo, Stefano
    Dore, Maria Pina
    Pes, Giovanni Mario
    Delitala, Giuseppe
    Delitala, Alessandro P.
    [J]. ANNALS OF MEDICINE, 2017, 49 (01) : 11 - 22
  • [7] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Ningwen Tai
    F. Susan Wong
    Li Wen
    [J]. Reviews in Endocrine and Metabolic Disorders, 2015, 16 : 55 - 65
  • [8] Gut microbiota and type 2 diabetes mellitus
    Munoz-Garach, Araceti
    Diaz-Perdigones, Cristina
    Tinahones, Francisco J.
    [J]. ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (10): : 560 - 568
  • [9] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Tai, Ningwen
    Wong, F. Susan
    Wen, Li
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (01): : 55 - 65
  • [10] Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer's Disease
    Naseer, Muhammad I.
    Bibi, Fehmida
    Alqahtani, Mohammed H.
    Chaudhary, Adeel G.
    Azhar, Esam I.
    Kamal, Mohammad A.
    Yasir, Muhammad
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 305 - 311